LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

BOAO, China, June 20, 2025 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, today launched the Cochlear™ Nucleus® Nexa™ System – th ...

Eight outstanding recipients of either the Cochlear™ Nucleus® Implant, Cochlear Baha® System and Cochlear Osia® System have been chosen for their abilities to uphold the Cochlear ideals of ...

The agency approved the company's Nucleus Hybrid L24 Cochlear Implant System for individuals 18 and older with severe or profound sensorineural hearing loss of high-frequency sounds in both ears, ...

Slower-than-expected sales growth over the past few months has led hearing implants giant Cochlear to cut its FY25 underlying profit expectations. Read Today's Paper Tributes. Rewards.

Upgradeable Firmware: The Cochlear™ Nucleus® Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access future innovation through firmware ...

The new Cochlear™ Nucleus® Nexa™ System is the first and only hearing implant featuring internal memory and upgradeable firmware.1+ This year marks the 30-year anniversary since the first adult ...

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of the Cochlear™ Nucleus® Nexa™ System ...

5 Mauger SJ, Warren C, Knight M, Goorevich M, Nel E. Clinical evaluation of the Nucleus 6 cochlear implant system: performance improvements with SmartSound iQ. International Journal Of Audiology ...